Skip to content
A message from Michel Sadelain, MD, PhD, Director of the Columbia Initiative in Cell Engineering and Therapy (CICET) at VP&S.
CICET’s GMP Facility advances cell and gene therapies with clean rooms, FDA standards, and quality systems to support safe early trials.
Our labs focus on advancing research in cell engineering and therapy to improve health outcomes.